Category: HIV Cure

HIV Has Been Cured For a 5th Time, Now Researchers Are Developing Scalable Methods

By AGT | Mar 6, 2023

Contributing Author Luke Williams, Sales and Marketing  A mounting body of evidence shows that HIV, once thought to be an incurable lifelong condition, is indeed curable. The “Dusseldorf Patient” made headlines recently when a stem cell transplant to treat life-threatening cancer also cured him of HIV. However, the transplantation method is incredibly dangerous and the availability of rare, HIV-resistant donor… [Read More]

The Biotech Project Podcast Dives into the Passionate Vision of Jeff Galvin

The Biotech Project Podcast Dives into the Passionate Vision of Jeff Galvin

By AGT | Jan 19, 2023

The Biotech Project podcast hosts Scott J Resnik, MBA, NYS EMT-CC, and John Walsh, MD, sit down with American Gene Technologies® founder and CEO Jeff Galvin for a lively and inspiring discussion.Watch the full episode to follow Jeff’s journey as he builds a company that’s on a path toward revolutionizing the traditional approach to treating diseases by daring to aim… [Read More]

AGT Phase 1 HIV Clinical Trial Data Published in Frontiers in Medicine

Phase 1 HIV Clinical Trial Data Published in “Frontiers in Medicine” Journal

By AGT | Dec 22, 2022

Contributing Author Luke Williams, Sales and Marketing  American Gene Technologies® (AGT) designed AGT103-T in hopes of functionally curing HIV. The therapeutic is made of the patient’s own T cells which have been enhanced for HIV resistance, and data from the Phase 1 human trial has recently been published in the journal Frontiers in Medicine. HIV is a curable condition, as… [Read More]

The Arc of HIV History 4

Chapter IV: Solving The Riddle, A Consequential Approach

By AGT | May 23, 2021

Contributing Author John Vandermosten, Senior Biotechnology Analyst The arc of HIV history has been developing over the last four decades.  In the early days there was much we did not know, but as teams of physicians, researchers and patients increased their understanding of the disease, progress was made.  Early efforts with repurposed cancer drugs gave way to numerous viral inhibitor combinations. … [Read More]

The Berlin Patient’s Success Produces A Flurry of Activity

By AGT | Dec 30, 2020

The Berlin Patient’s success provided optimism that there was a way to permanently disable HIV and eradicate it from an infected person.  While a bone marrow transplant is not appropriate for most HIV patients, what we have learned from his experience has provided us clues to find a cure.  Removing the door handle HIV uses to gain entry to immune… [Read More]

The History of HIV Cure Research: Reaching for a Cure

The History of HIV Cure Research: Reaching for a Cure

By AGT | Dec 8, 2020

Contributing Author: Gina Hagler A new immune deficiency illness came on the scene in 1981. In the years immediately following, four questions arose that indicated the uncertainty of the time: What was this illness? How was it transmitted? Could it be treated? Could it be cured? By 2004, when the number of people living with what we now knew as HIV… [Read More]

The History of HIV Cure Research: The Latest Research in BioPharma

By AGT | Dec 7, 2020

Contributing Author: Gina Hagler In the forty years since the HIV/AIDS pandemic began in 1981, researchers have learned a lot about this disease that destroys the immune system. Early on, they identified the method of transmission and the means of HIV replication. They went on to successfully turn what had been a deadly disease into a chronic illness through the daily… [Read More]

Why Is It So Difficult to Find an HIV Cure?

By AGT | Oct 22, 2020

More than 32 million people have died from AIDS-related illnesses since the start of the epidemic in 1981, making HIV/AIDS one of the greatest public health threats the world has known. Since it was first identified nearly 40 years ago, trillions of dollars have been spent by governments and private individuals on efforts to find effective treatments, vaccines, and a… [Read More]

In memory of Timothy Ray Brown

In Memory of Timothy Ray Brown

By AGT | Oct 2, 2020

Contributing Author : Jeff Galvin, CEO and Founder American Gene Technologies A Message From the CEO of American Gene Technologies® Timothy Ray Brown – March 11, 1966 – September 29, 2020 Timothy Ray Brown was both a person and a turning point in the arc of HIV history. Timothy received a bone marrow transplant and became functionally cured; a symbol… [Read More]

4 Global Trends That Will Affect ​HIV Cure​ Research in 2025

By AGT | Oct 2, 2020

Contributing Author: Gina Hagler Researchers have been working on an HIV Cure since the first reports of the illness appeared in 1981. We now have effective treatment in the form of a cocktail of antiretroviral drugs that stop the HIV virus’s progression to full-blown AIDS, but It is not a cure. Despite their benefits, antiretrovirals bring a shortened lifespan and… [Read More]

Subscribe to Our Newsletter

Subscribe to our newsletter to keep up to date with all the latest news about AGT!

Mailchimp sidebar

Follow AGT on Social Media